Fiscal Years (FY) 2015-2019 TPP Grant Recipient Evaluations

Just like the first cohort of Teen Pregnancy Prevention grant recipients (FY 2010-2014), each grant recipient in the FY 2015-2019 cohort is evaluating their efforts. These grant recipient-led evaluations are tied to the main goals of their respective grant tiers. The results or findings will provide information on how well they implemented their activities and the outcomes of that work.

Study Findings

Jump to a specific cohort:


Tier 1A: "Capacity Building to Support Replication of Evidence-Based Teen Pregnancy Prevention Programs"

Key Purpose

To fund intermediary organizations to provide capacity building assistance (CBA) to youth-serving organizations to replicate evidence-based TPP Programs in a defined service area with demonstrated need.

Community programs start with a set of defined resources (e.g., staff, knowledge, tools, etc.). That set of resources is the programs’ capacity to carry out TPP work. To grow and maintain their programs, program capacity also needs to grow. Each Tier 1A grant recipient provides support to a set of community organizations that are implementing evidence-based TPP programs.


Tier 1B: "Replicating Evidence-Based Teen Pregnancy Prevention Programs to Scale in Communities with the Greatest Need"

Key Purpose

To have a significant impact on reducing rates of teen pregnancy and existing disparities by replicating evidence-based TPP Programs to scale in multiple settings and with populations with the greatest need.

Tier 1B grant recipients are using evidence-based TPP program models, community mobilization, partnerships, and increased reach to have a community-wide impact on rates of teen pregnancy and existing disparities. The evaluation of their processes will help determine which strategies are effective in scaling up teen pregnancy prevention programs.

PDF content is undergoing Section 508 review and will be updated pending remediation. For immediate assistance, please contact: opa@hhs.gov.


Tier 2A: "Supporting and Enabling Early Innovation to Advance Adolescent Health and Prevent Teen Pregnancy"

Key Purpose

To enable and support early innovation to advance adolescent health and prevent teen pregnancy.

While evidence-based models exist, there is still much to learn about teen pregnancy prevention. Changes in technology, the places teens go to get support, and our understanding of how teens learn and make decisions, all offer opportunities for innovation. The two Tier 2A grant recipients have the responsibility to identify, fund, and support small groups of innovators (about five to 15 innovators per year) to test new approaches to teen pregnancy prevention. Their evaluation work will help identify approaches with promise as well as ways to measure the effects of these innovations.


Tier 2B: "Rigorous Evaluation of New or Innovative Approaches to Prevent Teen Pregnancy"

Key Purpose

To increase the number of evidence-based TPP interventions available by evaluating new or innovative approaches for preventing teen pregnancy and related high risk behaviors.

Some programs already have early or promising evidence that shows they can prevent teen pregnancy and related risk behaviors. Tier 2B grant recipients are setting up evaluations to rigorously test these programs. The evaluations will compare groups who receive the interventions against groups who do not (i.e., the test versus the control). This type of testing helps identify the effects of the program specifically. See descriptions of the new evaluations.

PDF content is undergoing Section 508 review and will be updated pending remediation. For immediate assistance, please contact: opa@hhs.gov.


Tier 2C: "Effectiveness of Teen Pregnancy Prevention Programs Designed Specifically for Young Males"

Key Purpose

To build evidence for what works to reduce young men’s risk for fathering a teen pregnancy.

While teen pregnancy prevention benefits all youth, many programs are targeted toward or mostly serve young women. OAH is partnering with the Centers for Disease Control and Prevention (CDC) to evaluate innovative approaches that specifically reduce the risk that young men between the ages of 15 and 24 become young fathers. These rigorous evaluations will also include qualitative data (e.g., interviews and focus groups) that will help add insight into what young men need in TPP efforts. See descriptions of the new evaluations.